In recent days, there have been many stocks which have recorded considerable losses and one of those is the EyeGate Pharmaceuticals Inc (NASDAQ:EYEG) stock. Over the course of the past week, the stock has been in the middle of a steady selloff and has actually gone down by as much as 22%.
On Wednesday, the company was in the news against owing to a key announcement and it may be a good idea to take a closer look into it. Yesterday, the company announced that it finally closed the registered direct offering that it had announced previously. The offering was priced as per the at the market rules of NASDAQ.
In this particular offering, EyeGate offered as many as 4,668,844 shares of the common stock for a price of $2.3025 and managed to generated gross proceeds to the tune of as much as $10.75 million. However, at the same time it should be remembered that the agent fees related to the registered direct placement and associated fees are going to be deducted from that sum.
In addition to that, EyeGate also offered unregistered warrants by way of which as many as 2,334,422 shares of the common stock can be picked up.